500 Participants Needed

Biomarker Study for Cardiovascular and Metabolic Diseases

SC
Overseen ByScott Cameron, MD, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: The Cleveland Clinic
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to study biomarkers, substances in the body that can indicate disease, to better understand cardiovascular (heart and blood vessel) and metabolic (energy use) diseases. Researchers at Cleveland Clinic seek to create a resource that facilitates collaboration between scientists and doctors in studying these diseases. Individuals diagnosed with or at risk for heart or metabolic diseases might be suitable candidates for this trial. As an unphased study, this trial offers a unique opportunity to contribute to groundbreaking research that could enhance future treatments.

Do I have to stop taking my current medications for the trial?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Why are researchers excited about this trial?

Researchers are excited about the Vascular Lab Resource (VLR) Biorepository because it focuses on biomarker analysis, which could revolutionize the way we understand and treat vascular conditions. Unlike current treatments that target symptoms or specific disease mechanisms, biomarker analysis aims to uncover unique biological indicators that can lead to earlier and more precise diagnoses. This approach has the potential to personalize treatment plans, ensuring that patients receive the most effective therapies based on their individual biological makeup. By identifying these biomarkers, researchers hope to pave the way for innovative therapies that are more effective and have fewer side effects compared to existing options.

Who Is on the Research Team?

SC

Scott Cameron, MD, PhD

Principal Investigator

The Cleveland Clinic

Are You a Good Fit for This Trial?

Inclusion Criteria

Subjects capable of providing informed consent document
Subjects with diagnosed with or at risk for cardiovascular and metabolic diseases

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Sample Collection

Collection of blood, urine, and/or stool samples for biorepository

Ongoing throughout the study

Follow-up

Participants are monitored for safety and effectiveness after sample collection

10 years

What Are the Treatments Tested in This Trial?

Interventions

  • Biomarker Analysis

Find a Clinic Near You

Who Is Running the Clinical Trial?

The Cleveland Clinic

Lead Sponsor

Trials
1,072
Recruited
1,377,000+
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security